Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
June 11, 2020
The added value of clinical radiopharmacists in nuclear medicine: The example of glomerular filtration rate assessment in kidney donors
Juliette Dinet, Stéphanie Becker, Joseph Le Cloirec, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 1, 2005
Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source
Dimitri Papathanassiou, Stéphanie Becker, Roland Amir, et al.
Plos One
|
February 8, 2019
Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
Mathieu N Toledano, Pierre Vera, Hervé Tilly, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 23, 2017
Predictive value of <sup>18</sup>F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial
Stéphanie Becker, Thomas Vermeulin, Anne-Ségolène Cottereau, et al.
Metabolites
|
February 3, 2021
Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?
Florian Eude, Mathieu Nessim Toledano, Pierre Vera, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
December 14, 2011
Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity
Stéphanie Becker, Nicolas Lepareur, Virginie Cadeillan, et al.
Leukemia & Lymphoma
|
December 8, 2020
SUV<sub>max</sub>-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin's lymphoma
Edgar Texte, Justine Lequesne, Hervé Tilly, et al.
Scientific Reports
|
December 2, 2021
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin's lymphoma
Pierre Pinochet, Edgar Texte, Aspasia Stamatoullas-Bastard, et al.
EJNMMI Reports
|
October 5, 2025
[<sup>123</sup>I]-mIBG and [<sup>18</sup>F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma
Agathe Edet-Sanson, Marine Lechevallier, Romain Modzelewski, et al.
EJNMMI Research
|
November 23, 2023
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors
Arnaud Dieudonné, Stéphanie Becker, Miguel Soares, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacy and Therapeutics
|
June 11, 2020
The added value of clinical radiopharmacists in nuclear medicine: The example of glomerular filtration rate assessment in kidney donors
Juliette Dinet, Stéphanie Becker, Joseph Le Cloirec, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 1, 2005
Respiratory motion artefact in the liver dome on FDG PET/CT: comparison of attenuation correction with CT and a caesium external source
Dimitri Papathanassiou, Stéphanie Becker, Roland Amir, et al.
Plos One
|
February 8, 2019
Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio
Mathieu N Toledano, Pierre Vera, Hervé Tilly, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 23, 2017
Predictive value of <sup>18</sup>F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial
Stéphanie Becker, Thomas Vermeulin, Anne-Ségolène Cottereau, et al.
Metabolites
|
February 3, 2021
Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?
Florian Eude, Mathieu Nessim Toledano, Pierre Vera, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
December 14, 2011
Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity
Stéphanie Becker, Nicolas Lepareur, Virginie Cadeillan, et al.
Leukemia & Lymphoma
|
December 8, 2020
SUV<sub>max</sub>-based assessment of PET response shows a superior specificity to Deauville criteria for predicting recurrence in Hodgkin's lymphoma
Edgar Texte, Justine Lequesne, Hervé Tilly, et al.
Scientific Reports
|
December 2, 2021
Prognostic value of baseline metabolic tumour volume in advanced-stage Hodgkin's lymphoma
Pierre Pinochet, Edgar Texte, Aspasia Stamatoullas-Bastard, et al.
EJNMMI Reports
|
October 5, 2025
[<sup>123</sup>I]-mIBG and [<sup>18</sup>F]-FDOPA differential uptake in the follow-up of neonatal neuroblastoma
Agathe Edet-Sanson, Marine Lechevallier, Romain Modzelewski, et al.
EJNMMI Research
|
November 23, 2023
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors
Arnaud Dieudonné, Stéphanie Becker, Miguel Soares, et al.
Page
of 4